All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-0322-LX41 | Anti-FRα (AFRA) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 | Human | AFRA | Human | scFv-CD28-OX40-CD3ζ | Lentiviral vector | T cell | ||
XS-0322-LX42 | Anti-FRα (C4) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 | Human | C4 | Human | scFv-CD28-OX40-CD3ζ | Lentiviral vector | T cell | ||
XS-0322-LX43 | Anti-FRα (m909) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 | Human | m909 | Human | scFv-CD28-OX40-CD3ζ | Lentiviral vector | T cell | ||
XS-0322-LX51 | Anti-FRα (LK-26) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 | Human | LK-26 | Mouse | scFv-CD28-OX40-CD3ζ | Lentiviral vector | T cell | ||
XS-0422-LX427 | Anti-FRα (AFRA) h(CD28-41BB-CD3ζ) CAR, pMMLV | Human | AFRA | Human | scFv-CD28-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
XS-0422-LX428 | Anti-FRα (C4) h(CD28-41BB-CD3ζ) CAR, pMMLV | Human | C4 | Human | scFv-CD28-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
XS-0422-LX429 | Anti-FRα (m909) h(CD28-41BB-CD3ζ) CAR, pMMLV | Human | m909 | Human | scFv-CD28-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
XS-0422-LX437 | Anti-FRα (LK-26) h(CD28-41BB-CD3ζ) CAR, pMMLV | Human | LK-26 | Mouse | scFv-CD28-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
XS-0822-YF2272 | Anti-Human FRα (XW-432) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-432 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2273 | Anti-Human FRα (XW-433) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-433 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2274 | Anti-Human FRα (XW-434) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-434 | Humanized | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2275 | Anti-Human FRα (XW-435) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-435 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF8541 | TS-Fluc Anti-Human FRα scFv (XW-432) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-432 | Mouse | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF8542 | TS-Fluc Anti-Human FRα scFv (XW-433) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-433 | Mouse | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF8543 | TS-Fluc Anti-Human FRα scFv (XW-434) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-434 | Humanized | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF8544 | TS-Fluc Anti-Human FRα scFv (XW-435) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-435 | Mouse | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF8545 | TS-Fluc Anti-Mouse FRα scFv (XW-436) CD28-CD3ζ CAR, pCDCAR1 | Mouse | XW-436 | Rat | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF8546 | TS-Fluc Anti-Mouse FRα scFv (XW-437) CD28-CD3ζ CAR, pCDCAR1 | Mouse | XW-437 | Rat | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF8547 | TS-Fluc Anti-Human FRα scFv (XW-438) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-438 | Mouse | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF8548 | TS-Fluc Anti-Human FRα scFv (XW-439) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-439 | Mouse | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION